Serious Adverse Effect of Benzbromarone Re-Emphasized

Published: 2005-01-12 06:55:00

Updated: 2005-01-12 06:55:00

The Korea Food and Drug Administration (KFDA) recently released an advisory letter addressed to the healthcare professionals on the reported mortality instances in Japan by medications containing benzbromarone, which is used for treatment of hyperuricemia (abnormally elevated blood level of uric ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK